What Are the Advantages and Disadvantages of Human Embryonic Kidney (HEK) Cells for the Analysis of Uptake Transporters?




Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Summary: Dr. Jörg König from the Institute for Experimental and Clinical Pharmacology and Clinical Toxicology at Friedrich-Alexander-University Erlangen-Nürnberg, Germany , speaks to Rebecca Maschke from Pharma IQ, about the analysis of transporter-mediated drug-drug interactions,